COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement
AJNR 41:2206-2208, Conte, G.,et al, 2020
Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir
Ann Neurol 93:88-102, Grundmann,A.,et al, 2023
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
COVID-19 Associated Myelitis Involving the Dorsal and Lateral White Matter Tracts
AJNR 42:1912-1917, Huang, H.Y.,et al, 2021
Changes in Stroke Hospital Care During the COVID-19 Pandemic
Stroke 52:3651-3660, Katsanos, A.H.,et al, 2021
Olfactory Dysfunction in COVID-19
JAMA doi:10.1001/JAMA.2020.8391, Whitcroft, K.L. & Hummel, T., 2020
Early Evidence of Pronounced Brain Involvement in Fatal COVID-19 outcomes
Lancet 395:e109, von Weyhern, C.H.,et al, 2020
Anosmia and Loss of Smell in the Era of COVID-19
BMJ 370:m2808, Walker, A.,et al, 2020
Steroid-Responsive Encephalitis in Coronavirus Disease 2019
Ann Neurol 88:423-427, Pilotto, A.,et al, 2020
Leukoencephalopathy Associated with Severe COVID-19
AJNR 41:1641-1645, Lang, M.,et al, 2020
Clinical and Neuroimaging Correlation in Patients with COVID-19
AJNR 41:1791-1796, Yoon, B.C., 2020
Covd-19-Associated Myopathy Caused by Type 1 Interferonopathy
NEJM 383:2389-2390, Manzano, A.C.,et al, 2020